1. Morton, GC. Early prostate cancer. Curr. Probl. Cancer 2000, 24: 5–51.
2. Goodin S, Rao KV, DiPaola RS. State-of-the-art treatment of metastatic hormone-refractory prostate cancer. Oncologist 2002, 7: 360–70.
3. Anwar K, et al. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res. 1992, 52: 5991–6.
4. Carter BS, Epstein JI, Isaacs WB. ras gene mutations in human prostate cancer. Cancer Res. 1990, 50: 6830–2.
5. Porter AT, Williams A, Forman JD. Adjuvant radiation therapy for pathologic T3 prostate cancer. Can. J. Urol. 1997, 4: 57–60.